Liquid Biotech USA

Liquid Biotech USA is a specialized biotechnology company focused on the development and commercialization of next-generation liquid biopsy technologies. The company utilizes a proprietary platform designed to isolate and analyze circulating tumor cells (CTCs) from peripheral blood with high sensitivity and specificity. This non-invasive approach allows for the longitudinal monitoring of cancer progression and treatment efficacy without the need for repeated surgical biopsies. Liquid Biotech USA's services are primarily utilized in oncology to detect minimal residual disease and guide personalized treatment strategies. The company maintains strong ties with academic institutions to validate its diagnostic assays across various solid tumor types, providing clinicians with real-time insights into a patient's tumor profile.